Application of targeted next generation sequencing technology in the diagnosis of Mycobacterium Tuberculosis and first line drugs resistance directly from cell-free DNA of bronchoalveolar lavage fluid

J Infect. 2023 Apr;86(4):399-401. doi: 10.1016/j.jinf.2023.01.031. Epub 2023 Jan 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bronchoalveolar Lavage Fluid / microbiology
  • Cell-Free Nucleic Acids*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Mycobacterium tuberculosis* / genetics
  • Sensitivity and Specificity
  • Technology

Substances

  • Cell-Free Nucleic Acids